Board of Directors
Ophthalmic Orphan Programs
Back of the Eye Diseases
Developing novel therapeutics
to treat ophthalmic diseases, with a focus on orphan and age-related retinal diseases
Ophthotech Reports Third Quarter 2017 Financial and Operating Results
Wednesday, November 8, 2017
Ophthotech Corporation to Report Third Quarter 2017 Financial Results and Host Conference Call on Wednesday, November 8, 2017
Monday, October 30, 2017
Ophthotech is a biopharmaceutical company specializing in the development of novel therapeutics to treat ophthalmic diseases, with a focus on orphan and age-related retinal diseases.
View Our Latest Corporate Presentation
Dr. Kourous Rezaei, Head of Medical Strategy at Ophthotech. "Image en Ophtalmologie" a publication of Edimark.